Medicare Enrolled

Dr. Anne Pawlak, D.O.

Neurology · Traverse City, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3922 CEDAR RUN RD, Traverse City, MI 49684
2313920430
In practice since 2005 (20 years)
NPI: 1891784484 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pawlak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pawlak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pawlak

Dr. Anne Pawlak is a neurology specialist in Traverse City, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pawlak performed 411 Medicare services across 371 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pawlak received a total of $9,232 from 46 pharmaceutical and/or device companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pawlak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 34% volume in MI $9,232 industry payments

Medicare Practice Summary

Medicare Utilization ↗
411
Medicare services
Top 34% in MI for neurology
371
Unique beneficiaries
$133
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
126 $89 $205
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
73 $114 $272
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
69 $126 $269
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
56 $63 $140
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
36 $340 $1,076
New patient office visit, complex (60-74 min) 33 $159 $344
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
18 $306 $791
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,232
Total received (2018-2024)
Avg $1,319/year across 7 years
Top 23% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
456
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,957 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$274 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$737
2023
$1,398
2022
$809
2021
$380
2020
$590
2019
$2,769
2018
$2,549

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$189
Biogen, Inc.
$147
Lilly USA, LLC
$87
Sumitomo Pharma America, Inc.
$80
CSL Behring
$68
ABBVIE INC.
$58
CATALYST PHARMACEUTICALS, INC.
$33
Genentech USA, Inc.
$27
Azurity Pharmaceuticals, Inc.
$17
TG Therapeutics, Inc.
$16
PFIZER INC.
$14
Top 3 companies account for 57.4% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,007
UCB, Inc.
$919
CSL Behring
$601
Novartis Pharmaceuticals Corporation
$546
US WorldMeds, LLC
$496
Amgen Inc.
$489
Avanir Pharmaceuticals, Inc.
$486
Teva Pharmaceuticals USA, Inc.
$411
Genentech USA, Inc.
$348
Otsuka America Pharmaceutical, Inc.
$313
Alnylam Pharmaceuticals Inc.
$275
Lilly USA, LLC
$269
Acorda Therapeutics, Inc
$263
Sunovion Pharmaceuticals Inc.
$244
EMD Serono, Inc.
$238
Alexion Pharmaceuticals, Inc.
$210
Grifols USA, LLC
$208
Eisai Inc.
$179
Adamas Pharmaceuticals, Inc.
$174
Sumitomo Pharma America, Inc.
$170
ABBVIE INC.
$149
Alkermes, Inc.
$125
PFIZER INC.
$124
Biohaven Pharmaceuticals, Inc.
$121
ACADIA Pharmaceuticals Inc
$119
Vertical Pharmaceuticals, LLC
$78
Celgene Corporation
$77
Biohaven Pharmaceutical Holding Company Ltd.
$64
MDD US Operations, LLC
$63
Impax Laboratories, Inc.
$48
Lundbeck LLC
$44
GENZYME CORPORATION
$44
Electromed, Inc.
$44
Janssen Pharmaceuticals, Inc
$40
CATALYST PHARMACEUTICALS, INC.
$33
E.R. Squibb & Sons, L.L.C.
$30
Bayer HealthCare Pharmaceuticals Inc.
$28
TG THERAPEUTICS, INC.
$22
Neurocrine Biosciences, Inc.
$22
EISAI INC.
$21
OWP Pharmaceuticals, Inc.
$17
Azurity Pharmaceuticals, Inc.
$17
TG Therapeutics, Inc.
$16
Allergan Inc.
$14
Mitsubishi Tanabe Pharma America, Inc.
$13
Zogenix Inc.
$13
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · ARISTADA · AUBAGIO · AUSTEDO · AVONEX · Activase · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CHANTIX · COMIRNATY · COPAXONE · EMGALITY · Enspryng · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HORIZANT · Haegarda · Hizentra · INBRIJA · INGREZZA · LEMTRADA · LYRICA · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · ONFI · ONPATTRO · OSMOLEX ER · PLEGRIDY · Privigen · RELEXXII · RYTARY · Radicava · Rebif · Rystiggo · SMARTVEST · SOLIRIS · Soliris · Subvenite · TECFIDERA · TYSABRI · UBRELVY · VUMERITY · Vimpat · XADAGO · XARELTO · Xadago · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Traverse City?
Compare neurologists in the Traverse City area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
9
Per 100K population
39.8
County median income
$91,943
Nearest hospital
MUNSON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pawlak is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pawlak experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pawlak performed 126 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pawlak receive payments from pharmaceutical companies?
Yes. Dr. Pawlak received a total of $9,232 from 46 companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pawlak's costs compare to other neurologists in Traverse City?
Dr. Pawlak's average Medicare payment per service is $133. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pawlak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →